TrialHuman vaccines & immunotherapeutics2021

A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients.

Patrice Chevallier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.